Brief: Living Cell Technologies Says Bernie Tuch Will Continue As Interim CEO Until End Of Jan 2023
31/10/2022 01:46
Oct 31 (Reuters) - Living Cell Technologies Ltd
LCT.AX :
* BERNIE TUCH WILL CONTINUE IN ROLE AS INTERIM CEO UNTIL END
OF
JANUARY 2023
Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program